Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonate BlendsKOAN FCF Margin % is -124.79% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 962 Drug Manufacturers companies, Resonate Blends ranks worse than 90.64% on this metric.
The historical data trend for Resonate Blends's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonate Blends FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Resonate Blends's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonate Blends (KOAN) has a FCF Margin % of -124.79% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Resonate Blends and its competitors. According to the industry distribution chart, Resonate Blends ranks #872 out of 962 companies in the Drug Manufacturers industry, placing it in the top 90.6%.
Is Resonate Blends' FCF Margin % too high?
Resonate Blends' current FCF Margin % is -124.79%. Based on the distribution chart, Resonate Blends ranks #872 out of 962 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Resonate Blends' FCF Margin % compare to PTPI and KAYS?
According to the Drug Manufacturers industry distribution chart, Resonate Blends ranks #872 out of 962 companies for FCF Margin %. This places Resonate Blends in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Resonate Blends and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonate Blends's current FCF Margin % is -124.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonate Blends stock overvalued right now?
Resonate Blends (KOAN) has a current FCF Margin % of -124.79%. The current FCF Margin % is -124.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Resonate Blends (KOAN), the current FCF Margin % is -124.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonate Blends Inc is engaged in the discovery, development, and marketing of nutritionally designed regenerative medicine and wellness products. The company focuses on natural stem cell mobilizing agents, diet aids, and bioactive formulations intended to enhance human performance and support health and wellness for consumer and professional markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KOAN has been successfully added to your 
